Strategic Network ClinEdge is now part of Elligo Health Research, positioning it within the largest healthcare enabling research organization. This enables cross sell and co selling opportunities across pharma sponsors, CROs, and site networks and provides a pathway to leverage Elligo's IntElligo technology for integrated trial management.

Lean Scale Advantage With a lean team of 11-50 and a broad network of research sites, ClinEdge offers a scalable, cost efficient model to deploy multiple site trials quickly. Target mid market sponsors seeking rapid site activation, enrollment acceleration, and predictable trial delivery.

Rare Disease Expertise ClinEdge has been recognized for excellence in rare disease drug development, signaling a differentiated capability that can win opportunities with sponsors pursuing niche programs. Position as a specialty partner with proven credibility.

Marketing Analytics The tech stack emphasizes marketing and analytics tools (HubSpot, Google Analytics, Google Tag Manager, Facebook Pixel), suggesting an opportunity to offer enhanced patient recruitment campaigns, site engagement optimization, and sponsor ROI dashboards.

Geographic Growth Historically active in North America with partnerships such as Skylight Health Group and expansion into Colorado, ClinEdge and its Elligo affiliation provide a platform to extend reach to more geographies and primary care networks, enabling scalable partnership driven growth for trials.